Press Releases

Date	Title
Nov 11, 2021	Summary Toggle Sol-Gel Technologies Reports Third Quarter 2021 Financial Results and Highlights Recent Corporate Developments
Nov 09, 2021	Summary Toggle Sol-Gel Technologies to Present Live at Jefferies London Healthcare Conference
Nov 04, 2021	Summary Toggle Sol-Gel Technologies Announces Sale of Generic Dermatology Portfolio to Partner Padagis for $21 Million
Sep 22, 2021	Summary Toggle Sol-Gel Technologies to Present at Upcoming Cantor Virtual Global Healthcare Conference
Sep 09, 2021	Summary Toggle Sol-Gel Technologies to Present at Upcoming H.C. Wainwright Global Investment Conference
Aug 04, 2021	Summary Toggle Sol-Gel Technologies Reports Second Quarter 2021 Financial Results and Highlights Recent Corporate Developments
Jul 27, 2021	Summary Toggle Sol-Gel Technologies Announces FDA Approval of TWYNEO®
Jul 20, 2021	Summary Toggle Sol-Gel Technologies to Report Second Quarter 2021 Financial Results on August 4th, 2021
Jun 28, 2021	Summary Toggle Sol-Gel Announces Pipeline Update and Future Development Plans
Jun 28, 2021	Summary Toggle Sol-Gel Technologies and Galderma Announce Exclusive Licenses for the Commercialization of EPSOLAY® and TWYNEO® in the United States